Incidence of Constipation Associated with Long-acting Opioid Therapy: A Comparative Study
Authors:
- Peter S. StaatsPSPeter S. Staats
- Jeffrey MarkowitzJMJeffrey Markowitz
- Jeffrey ScheinJSJeffrey Schein
- 1 February 2004
- journal article
- research article
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 97 (2) , 129-134
Abstract
Background: Opioid therapy plays a key role in the management of chronic pain. Constipation is one of the more frequently occurring adverse effects associated with opioid therapy. Methods: A retrospective cohort design study was conducted to determine the incidence of constipation in chronic pain patients who received three different long-acting opioids (transdermal fentanyl, oxycodone HCl...Keywords
This publication has 11 references indexed in Scilit:
- Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain – results of a double-blind placebo-controlled trial (MONTAS)Pain, 2002
- Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer painBMJ, 2001
- Insights into mu opioid pharmacologyLife Sciences, 2001
- Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphinePalliative Medicine, 2000
- Comparison of the Analgesic and Intestinal Effects of Fentanyl and Morphine in RatsJournal of Pain and Symptom Management, 1998
- Long-Term Treatment of Cancer Pain With Transdermal FentanylJournal of Pain and Symptom Management, 1998
- Transdermal fentanyl versussustained-release oral morphine in cancer pain: Preference, efficacy, and quality of lifeJournal of Pain and Symptom Management, 1997
- Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer painPain, 1996
- Insights into opioid action in the intestinal tractPharmacology & Therapeutics, 1996
- Transdermal fentanyl: a new step on the therapeutic ladderAnti-Cancer Drugs, 1995